CN102482644A - 用于卵母细胞的收集及成熟的方法 - Google Patents

用于卵母细胞的收集及成熟的方法 Download PDF

Info

Publication number
CN102482644A
CN102482644A CN2010800305832A CN201080030583A CN102482644A CN 102482644 A CN102482644 A CN 102482644A CN 2010800305832 A CN2010800305832 A CN 2010800305832A CN 201080030583 A CN201080030583 A CN 201080030583A CN 102482644 A CN102482644 A CN 102482644A
Authority
CN
China
Prior art keywords
oocyte
maturation
ivm
camp
oocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800305832A
Other languages
English (en)
Chinese (zh)
Inventor
R·B·吉克瑞斯特
J·汤普森
F·阿布兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation and Commercial Partners Pty Ltd
Original Assignee
Adelaide Research and Innovation Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adelaide Research and Innovation Pty Ltd filed Critical Adelaide Research and Innovation Pty Ltd
Publication of CN102482644A publication Critical patent/CN102482644A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN2010800305832A 2009-05-14 2010-05-14 用于卵母细胞的收集及成熟的方法 Pending CN102482644A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17831809P 2009-05-14 2009-05-14
US61/178,318 2009-05-14
PCT/AU2010/000569 WO2010130008A1 (en) 2009-05-14 2010-05-14 Methods for the collection and maturation of oocytes

Publications (1)

Publication Number Publication Date
CN102482644A true CN102482644A (zh) 2012-05-30

Family

ID=43084554

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800305832A Pending CN102482644A (zh) 2009-05-14 2010-05-14 用于卵母细胞的收集及成熟的方法

Country Status (8)

Country Link
US (1) US20120252119A1 (https=)
EP (1) EP2430154A4 (https=)
JP (1) JP2012526520A (https=)
KR (1) KR20120023097A (https=)
CN (1) CN102482644A (https=)
AU (1) AU2010246918A1 (https=)
CA (1) CA2761535A1 (https=)
WO (1) WO2010130008A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305837A (zh) * 2019-06-05 2019-10-08 西北师范大学 磷酸二酯酶5活性抑制剂作为诱导斑马鱼卵母细胞成熟的催熟剂的应用
CN115354019A (zh) * 2022-09-21 2022-11-18 华中农业大学 一种猪卵母细胞体外成熟培养液及其应用
CN116286615A (zh) * 2022-12-28 2023-06-23 中国农业大学 提高卵母细胞体外成熟率的培养基及其应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3037101B1 (en) 2014-12-22 2019-03-06 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
AU2017371402B2 (en) 2016-12-09 2024-02-22 Adelaide university Compositions and methods for maturation of oocytes in vitro
EP3790894B1 (en) 2018-05-09 2024-10-23 Monash University Modified gdf9 polypeptide monomer and method of promoting proliferation and differentiation of granulosa cells and oocyte maturation
KR102005807B1 (ko) 2018-06-25 2019-07-31 단국대학교 산학협력단 난자 성장 장치 및 이를 이용한 난자 성장 방법
CN114164168A (zh) * 2021-11-25 2022-03-11 苏州原一医疗科技有限公司 人卵母细胞-卵丘颗粒细胞复合体的体外成熟培养液及培养方法
CN117338902B (zh) * 2023-10-25 2024-07-09 南京医科大学 一种用于治疗卵子成熟障碍的复方制剂
CN120866198A (zh) * 2025-09-28 2025-10-31 苏州孚甲医疗科技有限公司 一种基于胎球蛋白的ivm无血清培养液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1235899B1 (en) * 1999-11-25 2007-03-21 Novo Nordisk A/S Treatment of human infertility
DE60321026D1 (de) * 2002-10-15 2008-06-26 Bayer Schering Pharma Ag In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3
FR2849380A1 (fr) * 2002-12-27 2004-07-02 Ernest Loumaye NOUVELLE UTILISATION D'UN AGONISTE DU GnRH
US7153824B2 (en) * 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305837A (zh) * 2019-06-05 2019-10-08 西北师范大学 磷酸二酯酶5活性抑制剂作为诱导斑马鱼卵母细胞成熟的催熟剂的应用
CN115354019A (zh) * 2022-09-21 2022-11-18 华中农业大学 一种猪卵母细胞体外成熟培养液及其应用
CN115354019B (zh) * 2022-09-21 2024-03-05 华中农业大学 一种猪卵母细胞体外成熟培养液及其应用
CN116286615A (zh) * 2022-12-28 2023-06-23 中国农业大学 提高卵母细胞体外成熟率的培养基及其应用

Also Published As

Publication number Publication date
US20120252119A1 (en) 2012-10-04
KR20120023097A (ko) 2012-03-12
WO2010130008A1 (en) 2010-11-18
EP2430154A1 (en) 2012-03-21
AU2010246918A1 (en) 2011-12-01
CA2761535A1 (en) 2010-11-18
JP2012526520A (ja) 2012-11-01
EP2430154A4 (en) 2014-01-08

Similar Documents

Publication Publication Date Title
CN102482644A (zh) 用于卵母细胞的收集及成熟的方法
Cognié et al. State-of-the-art production, conservation and transfer of in-vitro-produced embryos in small ruminants
Tesařík et al. Zona pellucida resistance to sperm penetration before the completion of human oocyte maturation
Menchaca et al. Oocyte developmental competence is improved by relatively greater circulating progesterone concentrations during preovulatory follicular growth
KR20010093276A (ko) 불임증 치료
Chian et al. IVM of human immature oocytes for infertility treatment and fertility preservation
Chian et al. In vitro maturation of immature human oocytes for clinical application
WO1997045531A1 (en) Gonadotrophin releasor hormone-containing composition and method for treating infertility
Guerif et al. Overnight incubation improves selection of frozen–thawed blastocysts for transfer: preliminary study using supernumerary embryos
Kharche et al. Factors influencing in-vitro embryo production efficiency of caprine oocytes: A review
Gonzalez-Bulnes et al. Induction of the presence of corpus luteum during superovulatory treatments enhances in vivo and in vitro blastocysts output in sheep
Davachi et al. Effects of co-incubation with conspecific ampulla oviductal epithelial cells and media composition on cryotolerance and developmental competence of in vitro matured sheep oocytes
EP1235899B1 (en) Treatment of human infertility
Yu et al. Effect of equine chorionic gonadotropin on the efficiency of superovulation induction for in vivo and in vitro embryo production in the cat
US20090233355A1 (en) Compositions and methods for culturing embryos and oocytes
US6544166B1 (en) Treatment of human infertility
Sanbuissho The effects of estrous cow serum on the maturation and fertilization of the bovine follicular oocyte in vitro
JP2006502717A (ja) インビトロでヒト卵母細胞の減数分裂停止
Boccia et al. 239 CAPACITATION OF BUFFALO SPERMATOZOA IN VITRO
US20140206930A1 (en) Twinning with sex sorted sperm
Santiago-Rodriguez et al. Evaluation of pig oocyte in vitro maturation and fertilization using three gonadotropin-based hormonal compounds
Chian et al. Effect of progesterone and/or estradiol-17β on sperm penetration in vitro of bovine oocytes
Hufana-Duran et al. In Vitro Embryo Production in Water Buffalo
YOON et al. OOCYTE IN VITRO MATURATION
Mehta In vitro maturation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120530